Top

Published in:

Open Access 01-12-2022 | Malaria | Study protocol

Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial

Authors: Semira Abdelmenan, Hiwot Teka, Jimee Hwang, Samuel Girma, Sheleme Chibsa, Eric Tongren, Matthew Murphy, Mebrahatom Haile, Dereje Dillu, Jawar Kassim, Sinknesh Behaksra, Fitsum G. Tadesse, Joshua Yukich, Yemane Berhane, Alemayehu Worku, Joseph Keating, Ayele Zewde, Endalamaw Gadisa

Published in: Trials | Issue 1/2022

Abstract

Background

Reactive and proactive case detection measures are widely implemented by national malaria elimination programs globally. Ethiopia decided to include Reactive Case Detection (RCD) and targeted Mass Drug Administration (tMDA) approaches as part of their elimination strategy along with rigorous evaluation. The purpose of this study is to compare the impact of RCD and tMDA on malaria elimination over the 2-year study period, by looking at the annual parasite incidence before and after the intervention.

Methods

The study will be conducted in the East Hararghe zone of Ethiopia. Malaria transmission in the area is low to moderate. This study will deploy a community-based, three-arm, cluster-randomized control trial implemented over 2 years. Forty-eight clusters (16 clusters per arm) will be selected based on the annual number of confirmed malaria cases seen in the cluster. All clusters will receive the current standard of care in terms of malaria elimination interventions provided by the national malaria control program. In addition, following the identification of malaria parasite infection, individuals who reside within a 100-m radius of the index case will receive a diagnosis for malaria and treatment if positive in the RCD arm or presumptive treatment in the tMDA arm. The primary effectiveness endpoint will be measured at baseline and endline for each intervention arm and compared to the control arm using a difference in difference approach.

Discussion

This randomized controlled trial will provide evidence of the impact of the proposed intervention approaches for malaria elimination.

Trial registration

ClinicalTrials.gov NCT04241705. Registration date: January 27, 2020.

World malaria report 2019 [Internet]. [cited 2022 Mar 7]. Available from: https://www.who.int/publications/i/item/9789241565721

Taffese HS, Hemming-Schroeder E, Koepfli C, Tesfaye G, Lee M, Kazura J, et al. Malaria epidemiology and interventions in Ethiopia from 2001 to 2016. Infect Dis Poverty. 2018;7(1):103. https://doi.org/10.1186/s40249-018-0487-3.CrossRefPubMedPubMedCentral

Federal Democratic Republic of Ethiopia Ministry of Health. National Malaria Strategic Plan: 2017 - 2020. Malaria Control and Elimination Program; 2017.

Deribew A, Dejene T, Kebede B, Tessema GA, Melaku YA, Misganaw A, et al. Incidence, prevalence and mortality rates of malaria in Ethiopia from 1990 to 2015: analysis of the global burden of diseases 2015. Malar J. 2017;16(1):271. https://doi.org/10.1186/s12936-017-1919-4.CrossRefPubMedPubMedCentral

Federal Democratic Republic of Ethiopia Ministry of Health. Malaria Diagnosis and Treatment Guidelines for Health Workers in Ethiopia. Disease Prevention and Control Directorate National Malaria Control and Elimination Program; 2017.

Ouattara AK, Bisseye C, Bazie BVJTE, Diarra B, Compaore TR, Djigma F, et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina Faso. Asian Pac J Trop Biomed. 2014 Aug;4(8):655–8. https://doi.org/10.12980/APJTB.4.2014APJTB-2014-0100.CrossRefPubMedPubMedCentral

Luzzatto L, Nannelli C, Notaro R. Glucose-6-Phosphate Dehydrogenase Deficiency. Hematol Oncol Clin North Am. 2016;30(2):373–93. https://doi.org/10.1016/j.hoc.2015.11.006.CrossRefPubMed

Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13(1):418. https://doi.org/10.1186/1475-2875-13-418.CrossRefPubMedPubMedCentral

Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Singhasivanon P, et al. Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics. Clin Infect Dis. 2011;52(5):612–20. https://doi.org/10.1093/cid/ciq249.CrossRefPubMedPubMedCentral

10.

Snounou G, White NJ. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol. 2004 Jul;20(7):333–9. https://doi.org/10.1016/j.pt.2004.05.004.CrossRefPubMed

11.

White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10(1):297. https://doi.org/10.1186/1475-2875-10-297.CrossRefPubMedPubMedCentral

12.

Filipe JAN, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC. Determination of the Processes Driving the Acquisition of Immunity to Malaria Using a Mathematical Transmission Model. PLOS Comput Biol. 2007;3(12):e255. https://doi.org/10.1371/journal.pcbi.0030255.CrossRefPubMedPubMedCentral

13.

Felger I, Maire M, Bretscher MT, Falk N, Tiaden A, Sama W, et al. The Dynamics of Natural Plasmodium falciparum Infections. PLOS ONE. 2012;7(9):e45542. https://doi.org/10.1371/journal.pone.0045542.CrossRefPubMedPubMedCentral

14.

Okell LC, Bousema T, Griffin JT, Ouédraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3(1):1237. https://doi.org/10.1038/ncomms2241.CrossRefPubMed

15.

Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12(12):833–40. https://doi.org/10.1038/nrmicro3364.CrossRefPubMed

16.

Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. Detection of a substantial number of sub-microscopic Plasmodium falciparum infections by polymerase chain reaction: a potential threat to malaria control and diagnosis in Ethiopia. Malar J. 2013;12(1):352. https://doi.org/10.1186/1475-2875-12-352.CrossRefPubMedPubMedCentral

17.

Golassa L, Baliraine FN, Enweji N, Erko B, Swedberg G, Aseffa A. Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia. BMC Infect Dis. 2015;15(1):310. https://doi.org/10.1186/s12879-015-1070-1.CrossRefPubMedPubMedCentral

18.

Tadesse FG, van den Hoogen L, Lanke K, Schildkraut J, Tetteh K, Aseffa A, et al. The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia. Malar J. 2017;16(1):99. https://doi.org/10.1186/s12936-017-1749-4.CrossRefPubMedPubMedCentral

19.

Ouédraogo AL, Gonçalves BP, Gnémé A, Wenger EA, Guelbeogo MW, Ouédraogo A, et al. Dynamics of the Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive Malaria Diagnosis in Burkina Faso. J Infect Dis. 2016;213(1):90–9. https://doi.org/10.1093/infdis/jiv370.CrossRefPubMed

20.

Tadesse FG, Slater HC, Chali W, Teelen K, Lanke K, Belachew M, et al. The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low-Endemic Setting in Ethiopia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;66(12):1883–91. https://doi.org/10.1093/cid/cix1123.CrossRef

21.

Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. 2013;11(6):623–39. https://doi.org/10.1586/eri.13.45.CrossRefPubMed

22.

Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, et al. “Asymptomatic” Malaria: A Chronic and Debilitating Infection That Should Be Treated. PLOS Med. 2016;13(1):e1001942.CrossRef

23.

Portugal S, Tran TM, Ongoiba A, Bathily A, Li S, Doumbo S, et al. Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;64(5):645–53. https://doi.org/10.1093/cid/ciw849.CrossRef

24.

Sturrock HJW, Hsiang MS, Cohen JM, Smith DL, Greenhouse B, Bousema T, et al. Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination. PLOS Med. 2013;10(6):e1001467. https://doi.org/10.1371/journal.pmed.1001467.CrossRefPubMedPubMedCentral

25.

Scott CA, Yeshiwondim AK, Serda B, Guinovart C, Tesfay BH, Agmas A, et al. Mass testing and treatment for malaria in low transmission areas in Amhara Region. Ethiopia. Malar J. 2016;15(1):305. https://doi.org/10.1186/s12936-016-1333-3.CrossRefPubMed

26.

CSA. Federal Democratic Republic of Ethiopia, Central Statistical Agency, Population Projection of Ethiopia for All Regions At Wereda Level from 2014 to 2017. 2017.

27.

Hillmen P, Hall C, Marsh JCW, Elebute M, Bombara MP, Petro BE, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;350(6):552–9. https://doi.org/10.1056/NEJMoa031688.CrossRefPubMed

28.

MOH. National Malaria Guidelines. Disease, Prevention and Control. Addis Ababa, Ethiopian Federal Ministry of Health. 2018.

29.

Hermsen CC, Telgt DS, Linders EH, van de Locht LA, Eling WM, Mensink EJ, et al. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol. 2001 Dec;118(2):247–51. https://doi.org/10.1016/S0166-6851(01)00379-6.CrossRefPubMed

30.

Wampfler R, Mwingira F, Javati S, Robinson L, Betuela I, Siba P, et al. Strategies for detection of Plasmodium species gametocytes. PloS One. 2013;8(9):e76316. https://doi.org/10.1371/journal.pone.0076316.CrossRefPubMedPubMedCentral

31.

Stone W, Sawa P, Lanke K, Rijpma S, Oriango R, Nyaurah M, et al. A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance. J Infect Dis. 2017;216(4):457–67. https://doi.org/10.1093/infdis/jix237.CrossRefPubMedPubMedCentral

32.

Kafsack BFC, Rovira-Graells N, Clark TG, Bancells C, Crowley VM, Campino SG, et al. A transcriptional switch underlies commitment to sexual development in human malaria parasites. Nature. 2014;507(7491):248–52. https://doi.org/10.1038/nature12920.CrossRefPubMedPubMedCentral

33.

Sinha A, Hughes KR, Modrzynska KK, Otto TD, Pfander C, Dickens NJ, et al. A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium. Nature. 2014 Mar 13;507(7491):253–7. https://doi.org/10.1038/nature12970.CrossRefPubMedPubMedCentral

34.

Poran A, Nötzel C, Aly O, Mencia-Trinchant N, Harris CT, Guzman ML, et al. Single-cell RNA sequencing reveals a signature of sexual commitment in malaria parasites. Nature. 2017;551(7678):95–9. https://doi.org/10.1038/nature24280.CrossRefPubMedPubMedCentral

35.

Wu L, Hall T, Ssewanyana I, Oulton T, Patterson C, Vasileva H, et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 2019;4:26. https://doi.org/10.12688/wellcomeopenres.14950.1.CrossRefPubMed

36.

Kerkhof K, Sluydts V, Willen L, Kim S, Canier L, Heng S, et al. Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J. 2016;15(1):529. https://doi.org/10.1186/s12936-016-1576-z.CrossRefPubMedPubMedCentral

Title: Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial
Authors: Semira Abdelmenan
Hiwot Teka
Jimee Hwang
Samuel Girma
Sheleme Chibsa
Eric Tongren
Matthew Murphy
Mebrahatom Haile
Dereje Dillu
Jawar Kassim
Sinknesh Behaksra
Fitsum G. Tadesse
Joshua Yukich
Yemane Berhane
Alemayehu Worku
Joseph Keating
Ayele Zewde
Endalamaw Gadisa
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Malaria
Plasmodium Vivax
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06199-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial

Abstract

Background

Methods

Discussion

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2022

Preoperative oral diazepam for intraoperative blood pressure stabilisation in hypertensive patients undergoing vitrectomy under retrobulbar nerve block anaesthesia: study protocol for a randomised controlled trial

Effects of osteopathic manipulative treatment associated with pain education and clinical hypnosis in individuals with chronic low back pain: study protocol for a randomized sham-controlled clinical trial

Increasing the effectiveness of psychotherapy in routine care through blended therapy with transdiagnostic online modules (PsyTOM): study protocol for a randomized controlled trial

Evaluating a tool to improve engagement and recruitment of under-served groups in trials

Super Bolus: a remedy for a high glycemic index meal in children with type 1 diabetes on insulin pump therapy?—study protocol for a randomized controlled trial

REACH-ASD: a UK randomised controlled trial of a new post-diagnostic psycho-education and acceptance and commitment therapy programme against treatment-as-usual for improving the mental health and adjustment of caregivers of children recently diagnosed with autism spectrum disorder